Appraisal of a newly developed ALBI-sarcopenia score as a prognostic marker in patients with hepatocellular carcinoma.
Maha ElsabaawyHanaa BadranAmr RagabRasha AbdelwahabEman SayedSameh AfifyWarda Othman
Published in: European journal of gastroenterology & hepatology (2024)
The newly introduced ALBI-sarcopenia score has demonstrated superior effectiveness in comparison to MELD-sarcopenia score, overcoming the shortcomings associated MELD score in forecasting outcomes for patients with HCC.